-
Most Popular

Biotech Stocks
Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

3 Promising Biotech Stocks for the Long-Term: August 2024
Some of the best biotech opportunities can be found in oversold obesity treatment stocks. Here are just a few.

The 3 Best Healthcare Stocks to Buy in August 2024
These are the best healthcare stocks that could bring in massive returns to the investors in the future. Do not miss out on this opportunity.
Recent Biotech Stocks Articles
Why Is Renalytix (RNLX) Stock Up 45% Today?
Renalytix (RNLX) stock is rising higher on Friday after the medical company got marketing permission from the FDA for a kidney test.
The 3 Most Undervalued Biotech Stocks to Buy Now: June 2023
If you dig deep enough, you’ll find some undervalued biotech stocks with substantial catalysts straight ahead.
Why Is Theriva Biologics (TOVX) Stock Up 60% Today?
Theriva Biologics (TOVX) stock is rocketing Wednesday after getting orphan drug designation from the FDA for its pancreatic cancer treatment.
3 Pharma Stocks That Have Big Investors Running for the Exit
Hedge funds, institutional investors and company insiders have been dumping shares of these risky pharma stocks.
Why Is Black Diamond Therapeutics (BDTX) Stock Up 82%?
Black Diamond Therapeutics (BDTX) stock is seeing massive gains on Tuesday after releasing data from a Phase 1 clinical study.
Why Is Bio-Path (BPTH) Stock Down 12% Today?
Bio-Path (BPTH) stock is sliding lower on Monday after the biotechnology company announced a proposed public share offering.
Why Is INVO Bioscience (INVO) Stock Up 82% Today
INVO Bioscience (INVO) stock is on the rise Monday after the company announced a public share offering on Friday morning.
Why Is AlloVir (ALVR) Stock Down 23% Today?
AlloVir (ALVR) stock is falling hard on Thursday after the company announced the pricing of a $75 million public share offering.
Why Is Ocean Biomedical (OCEA) Stock Up 26% Today?
Ocean Biomedical (OCEA) stock is rising higher on Wednesday after the company announced a price target increase from Fundamental Research.